UNeMed is hosting Dr. Brian Johns, Director of HIV Medicinal Chemistry at GlaxoSmithKline, on Tuesday October 8th. He will be giving a seminar titled “Making a Difference in HIV: The Discovery & Development of Tivicay®” in the DRC1 auditorium from 10-11 on October 8th. This seminar is meant to provide insight into the drug discovery process using their recently approved Tivicay as a case study. Although it is focused on an HIV drug, there will be valuable information for any researcher interested in pursuing drug discovery and drug development projects.